We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Modified Turmeric Compound Eases Symptoms Of Major Depressive Disorder

June 11, 2014: 12:00 AM EST
An Australian clinical trial that tested a proprietary curcumin-based supplement on 56 people diagnosed with major depressive disorder found that it worked better than a placebo on reducing self-reported depressive and anxiety symptoms. BCM-95 Curcumin, developed by DolCas Biotech, LLC, worked even better on people with atypical depression, which is generally more difficult to treat. Curcumin is the main curcuminoid derived from the spice turmeric. DolCas Biotech scientists developed a way to process curcumin – which is highly insoluble – to make it much more bioavailable and therefore therapeutically useful.
Adrian L. Lopresti et al., "Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study", Journal of Affective Disorders, June 11, 2014, © Elsevier Inc.
North America
United States of America
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.